21 CFR 888.3015
§ 888.3015 Bone heterograft.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 888.3015, § 888.3015 Bone heterograft, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91055
- Permanent ID
ys:prov:91055@1- SHA-256
abae7fbf9787b5982c75f5adc5917b0902a091f88af33e226d559ee4d41b729b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. Bone heterograft is a device intended to be implanted that is made from mature (adult) bovine bones and used to replace human bone following surgery in the cervical region of the spinal column.
(b) Classification. Class III.
(c) Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 888.3.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.